AI English summary of an SEC filing — figures as filed
The company completed its offering of 5.000% Senior Notes due 2029 $1.0 billion, 5.125% Senior Notes due 2031 $750 million, 5.250% Senior Notes due 2034 $1.25 billion and 5.600% Senior Notes due 2054 $1.5 billion on February 13, 2024.
Key points
AI summaryThe company completed its offering of 5.000% Senior Notes due 2029 $1.0 billion, 5.125% Senior Notes due 2031 $750 million, 5.250% Senior Notes due 2034 $1.25 billion and 5.600% Senior Notes due 2054 $1.5 billion on February 13, 2024.
The company said it intends to use the proceeds from the offering to pay the consideration for tender offers for up to $2.25 billion in aggregate principal amount of its outstanding notes maturing in 2024, 2025, 2026, 2027 and 2030, as previously announced.
The company said it plans to use the remaining proceeds from the offering, after the tender offers, to repay its 0.613% Senior Notes maturing in March 2024 and for general corporate purposes. The company said general corporate purposes may include debt repayment and repurchases of its common stock.
The company said the terms of the notes are governed by the Base Indenture dated September 17, 2018 and Supplemental Indenture No. 7, the 7th supplemental indenture to the Base Indenture dated February 13, 2024. The trustee is U.S. Bank Trust Company, National Association, and the notes were sold under the Form S-3ASR shelf registration statement.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Cigna completes 4-tranche senior notes offering on February 13, 2024
The company completed its offering of 5.000% Senior Notes due 2029 $1.0 billion, 5.125% Senior Notes due 2031 $750 million, 5.250% Senior Notes due 2034 $1.25 billion and 5.600% Senior Notes due 2054 $1.5 billion on February 13, 2024.
Source · Based on the filing body and exhibits
Planned use of offering proceeds for tender offer payments
The company said it intends to use the proceeds from the offering to pay the consideration for tender offers for up to $2.25 billion in aggregate principal amount of its outstanding notes maturing in 2024, 2025, 2026, 2027 and 2030, as previously announced.
Source · Based on the filing body and exhibits
Remaining proceeds to repay 2024 notes and for general purposes
The company said it plans to use the remaining proceeds from the offering, after the tender offers, to repay its 0.613% Senior Notes maturing in March 2024 and for general corporate purposes. The company said general corporate purposes may include debt repayment and repurchases of its common stock.
Source · Based on the filing body and exhibits
Base Indenture and 7th Supplemental Indenture
The company said the terms of the notes are governed by the Base Indenture dated September 17, 2018 and Supplemental Indenture No. 7, the 7th supplemental indenture to the Base Indenture dated February 13, 2024. The trustee is U.S. Bank Trust Company, National Association, and the notes were sold under the Form S-3ASR shelf registration statement.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…